wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26782522-D06AD00C-0FC6-4E57-993B-74441B679350
Q26782522-D06AD00C-0FC6-4E57-993B-74441B679350
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26782522-D06AD00C-0FC6-4E57-993B-74441B679350
LDL cholesterol, statins and PCSK 9 inhibitors
P2860
Q26782522-D06AD00C-0FC6-4E57-993B-74441B679350
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26782522-D06AD00C-0FC6-4E57-993B-74441B679350
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ca6e359a43548b2e444112b83d454e1259b5fe5
P2860
Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials.